Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant.
CONCLUSION: HepB-CpG has been shown to be as immunogenic as Engerix-B; however, long-term safety and persistence of immune memory has yet to be established.
PMID: 32988213 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Champion CR Tags: Ann Pharmacother Source Type: research
More News: Drugs & Pharmacology | Heart Attack | Hepatitis | Hepatitis B | Hepatitis Vaccine | Herpes | Shingles (Herpes Zoster) Vaccine | Study | Vaccines | Varicella-Zoster Virus Vaccine